Friday, Sep 25, 2020 | Last Update : 07:16 AM IST

185th Day Of Lockdown

Maharashtra128396397321434345 Andhra Pradesh6543855794745558 Tamil Nadu5636915082109076 Karnataka5485574446588331 Uttar Pradesh3742773076115366 Delhi2606232243755123 West Bengal2378692080424606 Odisha196888161044805 Telangana1792461481391070 Bihar174266159700878 Assam165582135141608 Kerala15445898720614 Gujarat1289491093113382 Rajasthan1227201023301352 Haryana118554984101177 Madhya Pradesh115361814752007 Punjab105220814752860 Chhatisgarh9562358833680 Jharkhand7643862945626 Jammu and Kashmir68614480791024 Uttarakhand4440432154501 Goa3055224347360 Puducherry2489519311467 Tripura2378616955245 Himachal Pradesh133869232125 Chandigarh109688342123 Manipur9537736959 Arunachal Pradesh8416607113 Nagaland5730459810 Meghalaya4733252838 Sikkim2447190529 Mizoram158510120
  Science   13 Sep 2020  Covaxin test on animals show sign of hope

Covaxin test on animals show sign of hope

THE ASIAN AGE.
Published : Sep 13, 2020, 3:27 pm IST
Updated : Sep 13, 2020, 3:27 pm IST

The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them

The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.
 The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.

Hyderabad: Animal results of the two-dose, unactivated SARS-Cov 2 vaccine, Covaxin BBV 152, has shown protection and reduction in the replication of SARS-Cov 2 virus in nose, throat and lung tissues.

The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them. The first dose of vaccine was given on Day 0 and the second dose was given on Day 14.

 

The results showed protective efficacy, increasing SARS-Cov 2-specific immunoglobulins which are antibodies, reducing replication of the virus.

Three groups of monkeys were given the vaccination and one group was not vaccinated. The three vaccinated groups did not develop pneumonia, while the non-vaccination group developed pneumonia.

According to the official note released by Bharat Biotech, there have not been any adverse side-effects noted in the animal trials.  There was a robust immune response as there was protection from SARS Cov-2 virus even when exposed in high amounts.

The results of Bharat Biotech are encouraging but there are queries raised about the effects on the central nervous system which have not been detailed in the animals.

 

Tags: covaxin trial, monkey, animal trial, bharat biotech
Location: India, Telangana, Hyderabad